GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

23 hedge funds and large institutions have $4.47M invested in Galmed Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
5
Calls
$31K
Puts
$16K
Net Calls
+$15K
Net Calls Change
+$393K

Top Buyers

1
RJFSA
1
Raymond James Financial Services Advisors
Florida
$101K
2
Cambridge Investment Research Advisors
2
Cambridge Investment Research Advisors
Iowa
$42K
3
Citadel Advisors
3
Citadel Advisors
Florida
$20K
4
Morgan Stanley
4
Morgan Stanley
New York
$263K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$1K

Top Sellers

1
II
1
Ibex Investors
Colorado
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Millennium Management
3
Millennium Management
New York
$17K
4
VF
4
Virtu Financial
New York
$0
5
NCM
5
Nantahala Capital Management
Connecticut
$412K
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$65K -200 Closed
LC
27
Lindbrook Capital
California
– -$21K -64 Closed
UBS Group
28
UBS Group
Switzerland
– -$12K -35 Closed
1
2